Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
A history of multiple sclerosis investigations in Canada between 1850 and 1950.
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Grey matter lesions in MS: From histology to clinical implications.
Tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis.
High spatial and angular resolution diffusion-weighted imaging reveals forniceal damage related to memory impairment.
ADEM Following Malaria.
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study.
TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls.
Promoting physical activity to control multiple sclerosis from childhood.
A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Magnetic resonance elastography reveals altered brain viscoelasticity in experimental autoimmune encephalomyelitis.
Reconstruction of the human cerebral cortex robust to white matter lesions: Method and validation.
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
Serum levels of LIGHT in MS.
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.
SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.
Idiopathic inflammatory demyelinating diseases of the brainstem.
Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis.
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Pages
« first
‹ previous
…
267
268
269
270
271
272
273
274
275
…
next ›
last »